Charles Lenz
A Specialist in Cardiology · Sanford Health
Credentials: · · · · ·
History
- Present
2019–2020- 2018–2019
- 2012–2015
Research
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Journal of Thrombosis and Haemostasis · 2020 · 435 citations
Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location
Mayo Clinic Proceedings · 2018 · 83 citations
Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial
Thrombosis and Haemostasis · 2017 · 55 citations
9 papers
9 papers
7 papers
4 papers
4 papers
- BS
4 papers
4 papers · 3 as a fellow
- CL
4 papers
